In neuroblastoma cells, the miR-17-92a cluster has been shown to impair TGF-β signaling pathway through miR-17 and −20a targeting of SMAD2, SMAD4 and transforming growth factor beta receptor 2 (TGFBR2) [16]. The gene discussed is TGFBR2; the disease is neuroblastoma.